Malaysia’s Felda Wellness seeks $300m Nasdaq listing
Botanical drug producer Felda Wellness Corporation is planning to raise $300m via a Nasdaq listing by March next year, which could see it become the first Malaysian firm to go public in the US.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts